Form 4 for KRRO Korro Bio, Inc.
Accepted 2021-12-21 00:00:00 ET · period of report 2021-12-20 · accession 0001127602-21-031694 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-21 | 2021-12-20 | KRRO | Lucchino David L. | Pres, CEO, Dir | M - OptEx | $0.61 | +6,905 | 463.2K | +2% | +$4,212 |
| D | 2021-12-21 | 2021-12-20 | KRRO | Lucchino David L. | Pres, CEO, Dir | M - OptEx | $0.00 | -6,905 | 6,905 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | M | A | 6,905 | $0.61 | 463,206 | D | — | — | |
| 2 | Derivative | Stock Option | 2021-12-20 | M | D | 6,905 | $0.00 | 6,905 | D | $0.61 · — to 2028-05-21 | 6,905 Common Stock | (F1) The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2018, and will be fully vested and exercisable on January 1, 2022. |